Literature DB >> 11747231

Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.

D C Chhieng1, E C Ko, H T Yee, J J Shultz, C C Dorvault, I A Eltoum.   

Abstract

Patients with small-cell lung carcinoma (SCLC) rarely present with pleural effusions. Based on morphology alone, recognition of SCLC in effusion cytology may be challenging because of the resemblance of neoplastic cells to lymphocytes. Immunocytochemistry may be helpful in its diagnosis. The objective of this study was to review the morphology and evaluate the use of immunocytochemistry in diagnosing SCLC in pleural fluids. Patients with SCLC who presented with pleural effusions were identified during a 6-yr period. The cytology and medical records were reviewed. Formalin-fixed, paraffin-embedded cell blocks of fluid specimens were immunostained with neuroendocrine markers (chromogranin A and synatophysin), cytokeratin 20 (CK20), and thyroid transcription factor-1 (TTF-1). The latter is a nuclear transcription protein that is expressed in normal respiratory epithelium and also in more than 90% of SCLCs. Of the 256 patients diagnosed with SCLC during the study period, 8 (2.7%) patients (3 females and 4 males, age range from 56-85 yr) also developed pleural effusions. One patient had 2 fluid specimens during the course of their disease, giving a total of 9 specimens. Four specimens had a positive cytologic diagnosis of SCLC, and 2 were initially diagnosed as suspicious for SCLC. The remaining 3 specimens were negative for SCLS. The specimens with a positive or suspicious diagnosis showed single and aggregates of small to medium-sized single cells with a high nuclear:cytoplasmic (N:C) ratio, round to angulated nuclei, and salt-and-pepper chromatin. Nuclear molding was also noted. Five out of 6 (83%) specimens with a positive or suspicious diagnosis of SCLC were positive for both chromogranin A and TTF-1. Synaptophysin was positive in 3 of 6 (50%) positive or suspicious cases. None of the cases were positive for CK20. All cases with a negative cytologic diagnosis were negative for chromogranin A, synatophysin, CK20, and TTF-1. In conclusion, patients with SCLC rarely present with pleural effusions. The cytology of SCLC is characteristic. The use of immunocytochemistry, particularly with antibodies to chromogranin A, TTF-1, and CK 20, aids in the differential diagnosis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747231     DOI: 10.1002/dc.10011

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  8 in total

Review 1.  Contemporary approach to the patient with malignant pleural effusion complicating lung cancer.

Authors:  Oleg Epelbaum; Najib M Rahman
Journal:  Ann Transl Med       Date:  2019-08

2.  Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.

Authors:  Jingquan Han; Shouqiang Cao; Kai Zhang; Guibin Zhao; Yanzhong Xin; Qing Dong; Yubo Yan; Jian Cui
Journal:  J Cardiothorac Surg       Date:  2012-11-13       Impact factor: 1.637

3.  A review of uncommon cytopathologic diagnoses of pleural effusions from a chest diseases center in Turkey.

Authors:  Ebru Cakir; Funda Demirag; Mehtap Aydin; Yurdanur Erdogan
Journal:  Cytojournal       Date:  2011-07-16       Impact factor: 2.091

4.  The cytomorphologic spectrum of small-cell carcinoma and large-cell neuroendocrine carcinoma in body cavity effusions: A study of 68 cases.

Authors:  Walid E Khalbuss; Huaitao Yang; Qian Lian; Abdelmonem Elhosseiny; Liron Pantanowitz; Sara E Monaco
Journal:  Cytojournal       Date:  2011-10-29       Impact factor: 2.091

5.  Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).

Authors:  M Fiegl; A Massoner; M Haun; W Sturm; H Kaufmann; R Hack; J Krugmann; M Fritzer-Szekeres; K Grünewald; G Gastl
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

6.  Pleural Small Cell Lung Carcinoma: An Unusual Culprit in Pleural Effusion.

Authors:  Oluwaseyi D Adejorin; Amik Sodhi; Felicia A Hare; Arthur S Headley; Luis C Murillo; Dipen Kadaria
Journal:  Am J Case Rep       Date:  2015-12-30

7.  Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer.

Authors:  Lin Tong; Ning Ding; Xiaoling Tong; Jiamin Li; Yong Zhang; Xiaodan Wang; Xiaobo Xu; Maosong Ye; Chun Li; Xue Wu; Hairong Bao; Xin Zhang; Qunying Hong; Yuanlin Song; Yang W Shao; Chunxue Bai; Jian Zhou; Jie Hu
Journal:  Theranostics       Date:  2019-07-28       Impact factor: 11.556

8.  Pleural small cell carcinoma with massive pleural effusion: A case report.

Authors:  Jong Geol Jang; Min Hye Jang; June Hong Ahn
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.